ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,421 | +7.7% | 19,805 | +11.9% | 0.12% | +15.2% |
| Q2 2023 | $2,248 | +57.3% | 17,704 | +59.9% | 0.10% | +50.0% |
| Q1 2023 | $1,429 | -6.4% | 11,073 | -4.7% | 0.07% | -12.5% |
| Q4 2022 | $1,527 | -99.9% | 11,624 | -3.5% | 0.08% | 0.0% |
| Q3 2022 | $1,409,000 | +27.1% | 12,044 | +27.7% | 0.08% | +40.4% |
| Q2 2022 | $1,109,000 | -11.6% | 9,433 | -2.0% | 0.06% | +5.6% |
| Q1 2022 | $1,255,000 | -6.8% | 9,622 | +9.1% | 0.05% | +3.8% |
| Q4 2021 | $1,346,000 | +37.5% | 8,818 | +45.8% | 0.05% | +23.8% |
| Q3 2021 | $979,000 | +10.0% | 6,050 | +11.3% | 0.04% | +5.0% |
| Q2 2021 | $890,000 | +13.5% | 5,436 | +4.3% | 0.04% | 0.0% |
| Q1 2021 | $784,000 | -6.7% | 5,210 | -6.0% | 0.04% | -14.9% |
| Q4 2020 | $840,000 | +2.7% | 5,540 | -8.3% | 0.05% | -11.3% |
| Q3 2020 | $818,000 | +124.7% | 6,040 | +127.1% | 0.05% | +96.3% |
| Q2 2020 | $364,000 | +19.0% | 2,660 | -6.3% | 0.03% | +3.8% |
| Q1 2020 | $306,000 | -15.0% | 2,840 | -5.0% | 0.03% | +4.0% |
| Q4 2019 | $360,000 | – | 2,990 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |